NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Manaksia Coated Metals Raises ₹150 Cr via QIP Allotment at ₹125/Share
Manaksia Coated Metals & Industries Limited approved the allotment of 1,19,99,847 equity shares under its Qualified Institutions Placement (QIP) at an issue price of ₹125 per share. The issue raised approximately ₹150 crore (₹149.998 crore), representing ~9.9% of its current market cap of ₹1,511 crore. Following the allotment, the company's total equity share base increased by 11.25% from 10,66,34,050 to 11,86,33,897 shares. Major allottees include Saint Capital Fund (30.00% of issue) and Uni Growth Fund (20.00% of issue).
உச்சம் நம்பிக்கை
என்ன மாறியதுCompleted QIP fundraise of ₹150 crore and allotted 1.20 crore equity shares to institutional investors, enlarging share capital by 11.25%.
ஏன் இது முக்கியம்The ₹150 crore injection strengthens the balance sheet (net worth stood at ₹380 crore; debt at ₹185 crore), offering funding for planned capacity expansions without further leveraging.
Total Funds Raised: ₹149,99,80,875Issue Price per Share: INR 125Shares Allotted: 1,19,99,847Fundraise vs Market Cap: ~9.9%Fundraise vs Net Worth: ~39.5%
📅 குறுகிய காலம்The issue price of ₹125 is below the current market price of ₹154.8, which may exert short-term price adjustments as newly allotted shares are credited and become tradeable.
📈 நீண்ட காலம்Substantially augments equity capital to support planned capacity expansions (Alu-zinc and color coating lines), improving financial leverage and execution bandwidth.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution of ~10.1% on the post-issue share capital
Execution risk in timely commissioning and scaling up new capacity lines
👀 கவனிக்க வேண்டியவை
Track the deployment of funds toward ongoing capex plans (such as the Alu-zinc line and second color coating line) and observe the corresponding promoter dilution impact in next quarterly shareholding filings.
Mphasis Q2 FY27 Results: Net Profit Up 19.6% YoY to ₹561.1 Cr, Revenue Grows 17.4% to ₹4,580.9 Cr
Mphasis reported its consolidated financial results for the quarter ended September 30, 2026, posting revenue from operations of ₹4,580.93 crore, up 17.4% YoY from ₹3,901.91 crore and 4.5% QoQ from ₹4,384.05 crore. Profit for the period grew 19.6% YoY to ₹561.13 crore compared to ₹469.07 crore in Q2 FY26 (up 14.6% QoQ from ₹489.51 crore). Diluted EPS for the quarter stood at ₹29.34 compared to ₹24.54 in the prior-year quarter. Growth was anchored by Banking and Financial Services, which delivered segment revenue of ₹2,474.04 crore, up 22.7% YoY.
உச்சம் நம்பிக்கை
என்ன மாறியதுApproval and release of audited Q2 and H1 FY27 standalone and consolidated financial results.
ஏன் இது முக்கியம்Demonstrates consistent double-digit revenue and PAT expansion led by the core BFSI vertical despite broader IT sector macroeconomic headwinds.
Q2 FY27 Revenue from operations: ₹4,580.93 கோடிQ2 FY27 Net Profit: ₹561.13 கோடிQ2 FY27 Diluted EPS: ₹29.34BFSI Segment Revenue: ₹2,474.04 கோடிH1 FY27 Revenue: ₹8,964.98 கோடி
📅 குறுகிய காலம்Earnings beat or in-line performance with sequential margin improvement should support stock sentiment in the near term.
📈 நீண்ட காலம்Sustained execution in AI-led solutions and high exposure to large banking clients position the firm to capture revival in enterprise technology budgets.
⚠ அபாய எச்சரிக்கைகள்
High geographic and client dependency on US BFSI and mortgage segments
Talent cost pressures and potential volatility in hedge-related adjustments
👀 கவனிக்க வேண்டியவை
Track management commentary on US BFSI discretionary spending and deal ramp-ups in subsequent quarters, alongside TCV deal win momentum.
Mphasis released its investor presentation for Q2 FY27, reporting quarterly gross revenue of $486 million, up 3.3% QoQ and 14.6% YoY. Operating margin stood steady at 14.8%, while quarterly EPS reached Rs 29.4 (up 14.8% from Q1 FY27). Net new TCV wins for the quarter were $466 million, with 66% being AI-led, bringing the trailing twelve-month (TTM) TCV to $1.8 billion. The company maintained its FY27 guidance of low double-digit constant-currency revenue growth and an operating margin band of 14.75% to 15.75%.
உச்சம் நம்பிக்கை
என்ன மாறியதுRelease of the detailed Q2 FY27 financial performance presentation alongside reaffirmation of full-year growth and margin targets.
ஏன் இது முக்கியம்Provides granularity on deal wins ($466M TCV) and increasing AI adoption (66% of wins, 71% of pipeline), which underpins future revenue visibility.
📅 குறுகிய காலம்Stable operating margins (14.8%) and healthy sequential growth in BFS Direct (4.5% QoQ) will likely support sentiment in the upcoming trading sessions.
📈 நீண்ட காலம்Rising proportion of AI-led deals (66% of TCV) and expanding pipeline offer structural support toward achieving the company's low double-digit growth trajectory.
⚠ அபாய எச்சரிக்கைகள்
DSO elongation to 113 days (normalized 105 days vs 89 days in Q2 FY26)
Significant dependence on US macro environment and BFS client spend
👀 கவனிக்க வேண்டியவை
Track the conversion rate of the $9,256 million pipeline into reported revenue and monitor if operating margins hold in the stated 14.75%-15.75% target band in H2 FY27.
Mufin Green Finance Q2 FY27: PAT Up 148.5% YoY to ₹15.06 Cr; AUM Reaches ₹1,766 Cr
Mufin Green Finance released its Q2 FY27 investor presentation, reporting a 148.5% YoY jump in standalone net profit to ₹15.06 Cr from ₹6.06 Cr in Q2 FY26. Gross AUM grew 71.8% YoY and 10.4% QoQ to ₹1,766.07 Cr, driven by rapid scaling in Mediclaim financing (₹686.90 Cr, 38.9% of AUM) and Salary Saathi loans (₹90.61 Cr). Asset quality improved with Gross NPA declining to 1.77% (down 14 bps QoQ) and Net NPA falling to 1.50%. The company maintained a strong capital adequacy ratio (CRAR) of 27.73%, well above the regulatory threshold of 15%.
உச்சம் நம்பிக்கை
என்ன மாறியதுCompany published detailed operational performance for Q2 FY27, highlighting a strategic portfolio tilt towards digital lending (Mediclaim and Salary Saathi).
ஏன் இது முக்கியம்Demonstrates strong operating leverage (AUM per employee rose to ₹5.77 Cr) and successful diversification away from pure climate finance into higher-velocity digital credit products.
📅 குறுகிய காலம்Market may react positively to the 148.5% YoY PAT surge and steady sequential improvement in asset quality metrics.
📈 நீண்ட காலம்Strategic shift to short-tenor, payroll-linked and mediclaim digital financing aims to lower credit losses and boost RoA, supporting long-term compounding if underwriting holds.
⚠ அபாய எச்சரிக்கைகள்
High interest expenses (₹52.91 Cr in Q2 FY27) putting pressure on spreads
Portfolio pivot towards newer digital loan products requires sustained underwriting validation
👀 கவனிக்க வேண்டியவை
Monitor whether the company meets its cost of borrowing target of <10.5% by March 2027 and observe asset quality trends as unsecured/payroll and mediclaim digital books scale.
Modi Naturals Q2 FY27 Consolidated Revenue Up 38.9% YoY to ₹204.9 Cr, PAT Rises 9.4% to ₹11.0 Cr
Modi Naturals reported consolidated revenue from operations of ₹204.90 Cr for Q2 FY27, marking a 38.9% YoY growth compared to ₹147.47 Cr in Q2 FY26. Consolidated profit after tax (PAT) grew 9.4% YoY to ₹11.02 Cr, up from ₹10.07 Cr in the prior-year period, though it contracted sequentially from ₹12.50 Cr in Q1 FY27. For H1 FY27, consolidated revenue stood at ₹361.95 Cr with a net profit of ₹23.53 Cr. Basic EPS for the quarter was ₹8.33, compared to ₹7.58 in Q2 FY26.
உச்சம் நம்பிக்கை
என்ன மாறியதுBoard approved unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.
ஏன் இது முக்கியம்Demonstrates robust top-line growth driven by the expansion in bulk and subsidiary operations (ethanol), though margin compression led to slower PAT growth relative to revenue.
Consolidated Revenue (Q2 FY27): ₹204.90 கோடிConsolidated PAT (Q2 FY27): ₹11.02 கோடிConsolidated Revenue (H1 FY27): ₹361.95 கோடிConsolidated PAT (H1 FY27): ₹23.53 கோடிDiluted EPS (Q2 FY27): ₹8.33Revenue vs TTM Revenue: ~28.5%
📅 குறுகிய காலம்Market may view strong top-line momentum positively, though sequential contraction in net profit (from ₹12.50 Cr to ₹11.02 Cr) could keep sentiment measured.
📈 நீண்ட காலம்Growth remains anchored in scaling the ethanol division via Modi Biotech Private Limited alongside branded consumer product penetration.
⚠ அபாய எச்சரிக்கைகள்
Raw material costs surged to ₹157.68 Cr in Q2 FY27 from ₹100.02 Cr in Q2 FY26, squeezing operating margins
Standalone bulk segment posted an EBIT loss of ₹75.93 Lakhs in Q2 FY27
👀 கவனிக்க வேண்டியவை
Track operating margin stability against rising raw material costs and monitor progress on the ethanol capacity expansion to 310 KLPD targeted for late 2025/2026.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Q2 FY27 Net Profit Rises 55.7% YoY to ₹4.40 Cr; Revenue Up 15.2% to ₹178.92 Cr
Muthoot Capital Services reported Q2 FY27 total income of ₹178.92 Cr, up 15.2% YoY compared to ₹155.28 Cr in Q2 FY26. Net profit for the quarter stood at ₹4.40 Cr, up 55.7% YoY from ₹2.83 Cr, though down sequentially by 45.8% compared to ₹8.12 Cr in Q1 FY27. Profitability was pressured quarter-on-quarter primarily by an increase in impairment provisions to ₹21.44 Cr versus ₹7.95 Cr in Q1 FY27. For H1 FY27, net profit rebounded to ₹12.52 Cr against a net loss of ₹1.84 Cr in H1 FY26.
உச்சம் நம்பிக்கை
என்ன மாறியதுAnnouncement of unaudited financial results for the quarter and half-year ended September 30, 2026.
ஏன் இது முக்கியம்Shows operational recovery from losses in H1 FY26, though sequential profit volatility persists due to higher credit provisions.
Total Income (Q2 FY27): ₹178.92 கோடிNet Profit (Q2 FY27): ₹4.40 கோடிImpairment on Financial Instruments (Q2 FY27): ₹21.44 கோடிNCD Fundraise utilized for on-lending: ₹250 கோடி
📅 குறுகிய காலம்Sequential profit drop from higher impairments may keep the stock range-bound despite healthy YoY revenue growth.
📈 நீண்ட காலம்Sustained turnaround depends on portfolio seasoning, controlling credit costs in vehicle finance, and execution of national AUM expansion plans.
⚠ அபாய எச்சரிக்கைகள்
Sharp QoQ increase in impairment provisions (₹21.44 Cr vs ₹7.95 Cr)
Cyclicality and credit risks inherent in retail vehicle and two-wheeler financing
👀 கவனிக்க வேண்டியவை
Track credit quality and credit cost trends in upcoming quarters, as the sharp sequential spike in impairment provisions impacted margins despite top-line growth.
Lemon Tree Q2 FY27 Total Revenue Up 18% YoY to ₹363.8 Cr; PAT Surges 90% to ₹79.8 Cr
Lemon Tree Hotels released its Q2 FY27 earnings presentation, showing strong operating leverage with total revenue rising 18% YoY to ₹363.8 crore and PAT surging 90% YoY to ₹79.8 crore. Occupancy improved by 633 bps YoY to 76.1%, while Gross ARR increased 8% YoY to ₹6,751, lifting RevPAR by 18% to ₹5,137. Balance sheet deleveraging continued, with gross debt reducing 11% YoY to ₹1,429.2 crore and cost of debt declining to 7.44%. The company added 8 hotels (523 rooms) and signed 11 hotels (825 rooms), expanding its operational and pipeline inventory to 24,061 rooms.
உச்சம் நம்பிக்கை
என்ன மாறியதுRelease of detailed Q2 & H1 FY27 earnings presentation, confirming strong operational turnaround and outlining progress on the Fleur Hotels demerger/listing.
ஏன் இது முக்கியம்Demonstrates operating leverage from midscale to upscale demand, expanding fee income (management fees up 19% to ₹40.8 crore), and a strengthening balance sheet with lower financing costs.
Q2 FY27 Total Revenue: ₹363.8 கோடிQ2 FY27 PAT: ₹79.8 கோடிNet EBITDA Margin: 44.6%Gross ARR: ₹6,751Gross Debt: ₹1,429.2 கோடிBandra Land Acquisition vs TTM Revenue: ~8.15%
📅 குறுகிய காலம்Market sentiment should react positively to the strong margin expansion, 90% PAT growth, and ARR trajectory ahead of the seasonal peak travel quarters (Q3/Q4).
📈 நீண்ட காலம்Strategic transition to an asset-light model via management contracts and expansion of high-margin upscale brands like Aurika, backed by the Fleur Hotels restructuring, underpins multi-year growth.
⚠ அபாய எச்சரிக்கைகள்
Execution and regulatory approval delays on large pipeline assets (e.g., Aurika Nehru Place awaiting final approvals)
Cyclicality in domestic travel demand and potential delays in third-party hotel openings
👀 கவனிக்க வேண்டியவை
Track the upcoming investor/analyst earnings call on November 11, 2026, and monitor progress on the Composite Scheme of Arrangement for Fleur Hotels' listing targeted for CY27.
SecMark Approves Incorporation of SecMark Mineral Exchange as Wholly Owned Subsidiary
SecMark Consultancy has approved the incorporation of a wholly owned subsidiary named SecMark Mineral Exchange Private Limited to establish and operate a Mineral Exchange. The initial subscription is 10,000 equity shares of Rs 10 each, totaling Rs 1,00,000 in cash, representing 100% control. The venture aims to manage clearing, trading, risk management, and physical settlement of mined natural resources and derivatives. Crucially, the exchange establishment is subject to regulatory approval from the Indian Bureau of Mines (IBM).
உச்சம் நம்பிக்கை
என்ன மாறியதுSecMark approved establishing a dedicated 100% subsidiary, SecMark Mineral Exchange Private Limited, rather than operating via its existing subsidiary Markets on Cloud Private Limited.
ஏன் இது முக்கியம்Marks an expansion from software and compliance consultancy into operating exchange infrastructure for natural resources, though it requires significant regulatory clearances.
Initial share capital subscription: Rs 1,00,000Shareholding percentage: 100%Subscription volume: 10,000 equity sharesSubscription price per share: Rs 10
📅 குறுகிய காலம்Limited financial impact in the near term given the nominal initial investment of Rs 1 lakh, but market sentiment may react to the new business vertical.
📈 நீண்ட காலம்Operating an exchange infrastructure could open a scalable transaction-based revenue stream beyond its consultancy business, contingent entirely on regulatory approval and execution.
⚠ அபாய எச்சரிக்கைகள்
Regulatory approval risk from the Indian Bureau of Mines (IBM)
Execution and high capital requirement risks associated with setting up exchange and clearing infrastructure
👀 கவனிக்க வேண்டியவை
Track the progress of regulatory approvals from the Indian Bureau of Mines and updates on capital expenditure requirements to launch the exchange platform.
JUBLPHARMA Allots ₹800 Cr Unsecured NCDs at 8.50% Coupon
Jubilant Pharmova has approved the allotment of 80,000 unsecured, rated, listed, redeemable Non-Convertible Debentures (NCDs) aggregating to ₹800 crore on a private placement basis. The NCDs carry a face value of ₹1,00,000 each and will be listed on the BSE. The issue carries an interest rate of 8.50% per annum with a tenure of 3 years (maturity dated November 5, 2028). The ₹800 crore borrowing is significant relative to the company's current reported debt of ₹53 crore and represents ~34.6% of its net worth (₹2,312 crore).
உச்சம் நம்பிக்கை
என்ன மாறியதுJubilant Pharmova successfully issued ₹800 crore worth of 3-year unsecured NCDs via private placement.
ஏன் இது முக்கியம்The borrowing injects substantial liquidity for expansion or refinancing, but it will raise overall debt levels and increase annual interest outgo by roughly ₹68 crore.
Issue Size: Rs. 800 கோடிCoupon Rate: ஆண்டுக்கு 8.50%Number of NCDs: 80,000Tenure: 3 YearsIssue Size vs Net Worth: ~34.6%
📅 குறுகிய காலம்Short-term balance sheet leverage increases significantly, while annual interest costs will rise by ₹68 crore.
📈 நீண்ட காலம்Supports ongoing capex plans including the CAD 145M Montreal sterile injectables expansion; returns will depend on project execution and commissioning.
⚠ அபாய எச்சரிக்கைகள்
Increased finance cost burden of ₹68 crore per annum
Unsecured debt structure
👀 கவனிக்க வேண்டியவை
Track the deployment of funds towards ongoing capex (such as the Montreal CDMO facility) and monitor interest cost impacts on quarterly profitability in upcoming quarters.
Nimbus Projects Limited has finalized terms to avail an unsecured credit facility of up to Rs 60.00 crore from its associate company and promoter group entity, Nimbus (India) Limited. The loan carries an interest rate of 12% per annum with a tenure of 2 years and will be disbursed in tranches for business purposes. The borrowing is significant, representing approximately 28% of the company's existing debt of Rs 211 crore and 26% of TTM revenue. Shareholders previously approved this related-party transaction via special resolution at the AGM on September 29, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe Board has finalized terms to draw down up to Rs 60 crore in unsecured debt from associate NBFC Nimbus (India) Limited.
ஏன் இது முக்கியம்Provides near-term liquidity for operations, but adds substantial interest burden to a company that reported negative TTM operating margins and net losses.
கடன் தொகை: Rs 60.00 Croreவட்டி விகிதம்: 12% per annumTenure: 2 yearsLoan vs existing debt: ~28.4%Loan vs TTM revenue: ~26.4%
📅 குறுகிய காலம்Eases working capital needs, but market focus will be on the high borrowing rate (12%) and related-party nature of the borrowing.
📈 நீண்ட காலம்Adds leverage to an already indebted balance sheet (D/E at 0.98), necessitating faster execution and revenue recognition to service debt.
⚠ அபாய எச்சரிக்கைகள்
Related-party transaction involving common promoter and director
Relatively high cost of debt at 12% p.a.
Elevated financial leverage on negative TTM net margins
👀 கவனிக்க வேண்டியவை
Track the deployment of funds toward project completion and monitor the interest cost impact on quarterly operating margins, given the 12% borrowing cost.
AMCL H1 FY27 Revenue Jumps 78.6% YoY to ₹156.78 Cr; Net Profit Rises 35.7% to ₹11.53 Cr
ANB Metal Cast Limited reported standalone financial results for the half year ended September 30, 2026. Revenue from operations grew 78.6% YoY to ₹156.78 crore compared to ₹87.80 crore in the half year ended September 30, 2025. Net profit rose 35.7% YoY to ₹11.53 crore from ₹8.49 crore in the prior-year period. However, operating cash flows remained negative at -₹19.07 crore due to substantial working capital lockups in trade receivables and inventories.
உச்சம் நம்பிக்கை
என்ன மாறியதுAMCL reported half-yearly standalone earnings showing strong top-line and bottom-line expansion alongside updates on the deployment of IPO issue proceeds.
ஏன் இது முக்கியம்Demonstrates rapid revenue growth and scaling post-listing, though accompanied by significant working capital expansion and negative operating cash flows.
📅 குறுகிய காலம்Market may react positively to the strong 78.6% top-line growth and 35.7% PAT increase, tempered by negative operating cash flows.
📈 நீண்ட காலம்Sustained revenue momentum depends on the successful commissioning of additional plant and machinery and converting receivables into positive cash flows.
⚠ அபாய எச்சரிக்கைகள்
Negative operating cash flow (-₹19.07 cr) driven by rising trade receivables (₹103.91 cr) and inventories (₹89.85 cr)
Increase in short-term and long-term borrowings
👀 கவனிக்க வேண்டியவை
Track the commissioning of the remaining ₹2.10 crore capex and watch whether operating cash flow normalizes as working capital cycles play out in H2.
Nimbus Projects Q2 FY27 Standalone Net Loss at ₹9.58 Cr; H1 Presales Up 36.4% to ₹235.49 Cr
Nimbus Projects reported its financial results for the quarter and half-year ended September 30, 2026. For Q2 FY27, standalone revenue from operations stood at ₹0.38 Cr (₹37.66 lakhs), with a net loss after tax of ₹9.58 Cr (₹957.70 lakhs) compared to a loss of ₹25.78 Cr in Q2 FY26. For the Nimbus Group, H1 presales booking value grew 36.41% YoY to ₹235.49 Cr (23,549 lakhs) compared to ₹172.63 Cr in H1 FY26, while customer collections increased 12.73% to ₹129.86 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுNimbus Projects announced its Q2 and H1 FY27 standalone and consolidated financial results along with project presale updates.
ஏன் இது முக்கியம்While the company continues to post operational and net losses at the standalone level, operational presales and collection volumes reflect ongoing cash generation at the project level.
Standalone Q2 Revenue: 37.66 LakhsStandalone Q2 Net Loss: (957.70) LakhsH1 Group Presales Value: 23,549 LakhsH1 Customer Collection: 12,986 LakhsInvestments in Projects till Sep 2026: Rs.440.86 Crore
📅 குறுகிய காலம்Market response is likely to remain muted given persistent standalone quarterly losses despite improved presale momentum.
📈 நீண்ட காலம்Long-term recovery relies on completing ongoing projects, debt containment, and translating presales into recognized consolidated revenues.
⚠ அபாய எச்சரிக்கைகள்
Continued standalone net losses and drag from partnership firm losses
Elevated borrowing levels (Consolidated non-current borrowings at ₹27,786.32 lakhs)
👀 கவனிக்க வேண்டியவை
Track conversion of presales bookings into revenue recognition and cash flows from ongoing projects like The Palm Village and The Arista Luxe.
Karamtara Q2 FY27 Net Profit Rises 37% YoY to ₹94.6 Cr; Revenue Up 62%
Karamtara Engineering released its Q2 and H1 FY27 investor presentation, reporting consolidated Q2 FY27 revenue from operations of ₹1,646.7 crore (up 62% YoY) and net profit of ₹94.6 crore (up 37% YoY). EBITDA for the quarter reached ₹196.2 crore, expanding 46% YoY, although EBITDA margins contracted to 11.9% from 13.2% in Q2 FY26. Solar energy products formed the core driver, contributing 71% of Q2 FY27 revenue, followed by transmission lattice towers at 21%. Additionally, the company announced it is evaluating entering defence and aerospace via a proposed wholly-owned subsidiary.
உச்சம் நம்பிக்கை
என்ன மாறியதுRelease of the comprehensive Q2/H1 FY27 performance deck detailing revenue mix, balance sheet position, and a planned foray into defence & aerospace manufacturing.
ஏன் இது முக்கியம்Demonstrates strong top-line scale driven by global solar module mounting structures, though margin compression reflects rising operating and raw material expenses.
📅 குறுகிய காலம்Market sentiment should stay positive given the 62% YoY top-line expansion, though earnings call questions will likely focus on EBITDA margin compression from 13.2% to 11.9%.
📈 நீண்ட காலம்With an 879,800 MT p.a. saleable capacity and deep backward integration in solar infrastructure and transmission, the company remains well-positioned, though capital deployment in defence remains early-stage.
⚠ அபாய எச்சரிக்கைகள்
Margin contraction of 130 bps YoY in Q2 FY27
Heavy reliance on solar energy products (71% of Q2 revenue)
Significant debt burden of over ₹1,000 Cr (₹10,041 Mn)
👀 கவனிக்க வேண்டியவை
Track commentary from the earnings call scheduled for November 06, 2026, particularly regarding margin stability amidst higher input costs and updates on the proposed defence subsidiary.
AUM Reaches ₹3,530 Cr (+4.5% QoQ) in Q2 FY27; Q2 PAT Reported at ₹4.11 Cr
Muthoot Capital Services released its investor presentation for Q2 FY27, reporting an overall AUM of ₹3,530 crore (up 4.5% QoQ and 4.5% YoY), driven by an 8% QoQ expansion in its own retail book to ₹3,086 crore. Total disbursements during Q2 grew 21% QoQ to ₹649.43 crore (or ₹677 crore including managed book), with two-wheeler loans accounting for ~70% of AUM. Asset quality showed a mixed trend: overall GNPA stood at 4.61% (and 4.81% on off-book inclusion) vs 6.46% in Q2 FY26, but deteriorated sequentially from 3.94% in Q1 FY27. Net profit for the quarter was reported at ₹4.11 crore with portfolio yields holding steady at ~22%.
உச்சம் நம்பிக்கை
என்ன மாறியதுFiling of the comprehensive investor presentation outlining operational, financial, and asset quality metrics for Q2 FY27.
ஏன் இது முக்கியம்Provides granular operational data showing growth in vehicle retail lending, a steady 22% yield, but a sharp drop in co-lending partnerships and a sequential rise in NPAs.
📅 குறுகிய காலம்Market focus will center on management commentary during the earnings call regarding the sequential increase in gross NPAs and the total wind-down in new co-lending originations.
📈 நீண்ட காலம்Progress toward the company's stated goal of reaching ₹10,000 Cr AUM by 2028 depends on successfully scaling used-car and commercial vehicle financing outside South India.
⚠ அபாய எச்சரிக்கைகள்
Sequential uptick in GNPA to 4.81% (closing gross NPAs rose to ₹160.11 Cr from ₹130.07 Cr in June 2026)
Co-lending disbursement fell to ₹0 Cr in Q2, down 100% QoQ
High geographical concentration with South India representing 38% of retail AUM
👀 கவனிக்க வேண்டியவை
Monitor asset quality stabilization following the sequential uptick in GNPA (from 3.94% to 4.61%), alongside updates from the investor conference call on November 06, 2026.
LXCHEM Q2 FY27: Revenue Jumps 55% YoY to ₹1,083 Cr, PAT Surges 418% to ₹57 Cr
Laxmi Organic Industries released its Q2 FY27 investor presentation reporting strong financial performance. Consolidated revenue from operations grew 54.7% YoY to ₹1,082.7 Cr (INR 10,827 Mn), driven by a 61% surge in the Essentials division following the stabilization of Ethyl Acetate capacity at Lote. EBITDA expanded 191.3% YoY to ₹108.0 Cr with margins expanding 470 bps to 10.0%, while PAT jumped 417.6% YoY to ₹57.0 Cr. Sequentially, however, EBITDA declined 5.5% and PAT fell 15.8% compared to Q1 FY27 due to raw material and operating expense pressures.
உச்சம் நம்பிக்கை
என்ன மாறியதுLaxmi Organic posted robust YoY earnings growth for Q2 FY27 and announced the commissioning of its new diketene capacity at Dahej alongside stabilized Ethyl Acetate capacity at Lote.
ஏன் இது முக்கியம்Higher capacity utilization and cost pass-through are restoring operating leverage and margins, supporting the company's strategic aim to become a top-3 global player in diketene derivatives.
📅 குறுகிய காலம்The strong YoY earnings rebound and capacity commissioning provide positive sentiment, though sequential contraction in EBITDA (-5.5% QoQ) and PAT (-15.8% QoQ) signals ongoing margin normalization.
📈 நீண்ட காலம்Expansion into higher-margin diketene derivatives and specialty fluorochemicals at Dahej should diversify revenue away from commodity Ethyl Acetate and improve long-term blended ROCE.
⚠ அபாய எச்சரிக்கைகள்
Feedstock cost volatility that cannot be immediately passed on to contract customers
Execution and ramp-up risks at Dahej Phase II
👀 கவனிக்க வேண்டியவை
Track the commercial ramp-up and customer qualification of the newly commissioned Dahej diketene capacity across Q3 and Q4 FY27, along with margin sustainability amid feedstock price volatility.
Kusumgar Q2 FY27 PAT Jumps 272% YoY to ₹40.6 Cr; Revenue Up 81% YoY to ₹250.9 Cr
Kusumgar Limited released its Q2 FY27 earnings presentation, posting an 81% YoY jump in revenue to ₹2,509 Mn (₹250.9 Cr) and a 272% surge in PAT to ₹406 Mn (₹40.6 Cr). EBITDA grew 132% YoY to ₹713 Mn, with EBITDA margin expanding 600 bps YoY to 28%, although it contracted 300 bps QoQ from 31% in Q1 FY27. For H1 FY27, revenue climbed 91% YoY to ₹4,982 Mn while PAT rose 374% YoY to ₹832 Mn. The company incurred ₹44.1 Cr in capex during H1 FY27, primarily directed toward debottlenecking and maintenance.
உச்சம் நம்பிக்கை
என்ன மாறியதுKusumgar published its Q2 and H1 FY27 investor presentation and earnings Q&A, disclosing robust YoY growth in both top line and net profitability alongside operational details.
ஏன் இது முக்கியம்Demonstrates strong operational leverage and product mix enrichment in its core aerospace and defence business, with H1 FY27 profit (₹832 Mn) already approaching full-year FY26 PAT (₹982 Mn).
📅 குறுகிய காலம்Market sentiment will likely react positively to the strong 272% YoY net profit growth and resilient 28% margin performance.
📈 நீண்ட காலம்As an incumbent supplier to Indian armed forces with expanding export and OEM qualification pipelines, the company is structurally positioned to benefit from defence indigenisation.
⚠ அபாய எச்சரிக்கைகள்
High dependence on government/defence procurement and inspection cycles, leading to working capital fluctuations (100–120 days)
Significant exposure to imported materials (38.91% in FY26)
No order book disclosure provided due to customer confidentiality
👀 கவனிக்க வேண்டியவை
Track the progression of product qualifications with armed forces and OEM customers, as well as stability in raw material costs and product mix to see if ~28-30% EBITDA margins can be sustained.
Q2 FY27 Net Profit Rises 26.6% YoY to ₹2.94 Cr; EBITDA Margin Expands to 7.1%
VTM Limited reported its Q2 FY27 results, with revenue from operations growing 9.2% YoY to ₹98.17 crore compared to ₹89.88 crore in Q2 FY26. Net profit rose 26.6% YoY and 52.1% QoQ to ₹2.94 crore, supported by an improved product mix lowering net material costs to 59.8% of sales. EBITDA margin widened to 7.1% from 5.6% in Q2 FY26, despite a 21.6% rise in other expenses from selling and customer acquisition efforts. For H1 FY27, net profit stood at ₹4.87 crore on revenue of ₹196.57 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுVTM reported Q2 FY27 earnings with operating revenue up 9.2% YoY and PAT jumping 26.6% YoY to ₹2.94 crore.
ஏன் இது முக்கியம்A more favorable product mix drove gross margin expansion to 40.2%, partially shielding profitability from higher employee costs and selling/distribution expenses.
📅 குறுகிய காலம்Earnings show operational improvement with expanding margins, which may support sentiment in the near term.
📈 நீண்ட காலம்Long-term performance hinges on sustaining export/domestic demand and maintaining raw material cost advantages amid rising overheads.
⚠ அபாய எச்சரிக்கைகள்
Sharp 116% YoY surge in finance costs to ₹86.05 Lakhs
Rising employee benefit expenses driven by compliance and labor code adjustments
Elevated selling and distribution costs required to retain clients and explore new markets
👀 கவனிக்க வேண்டியவை
Track whether gross margin expansion from the improved product mix sustains in upcoming quarters against rising selling expenses and finance costs.
Lemon Tree Approves Q2 FY27 Results; Advances Corporate Restructuring Scheme to NCLT
Lemon Tree Hotels announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company provided an update on its Composite Scheme of Arrangement to segregate its hotel ownership and hotel management businesses, confirming it received NSE and BSE approvals on September 22, 2026, and filed an application with the NCLT Chandigarh Bench on October 09, 2026. The scheme has an appointed date of April 01, 2026, and previously received CCI approval on April 07, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுApproval of Q2 FY27 unaudited results and formal progress of the corporate demerger scheme into NCLT following stock exchange approvals.
ஏன் இது முக்கியம்The corporate restructuring will structurally separate capital-heavy hotel assets from asset-light management contracts, impacting return ratios and business profiles.
NCLT Filing Date: அக்டோபர் 09, 2026Stock Exchange No-Objection Date: செப்டம்பர் 22, 2026Reviewed Subsidiaries Q2 Revenue: Rs 7,167.73 lakhsScheme Appointed Date: ஏப்ரல் 01, 2026
📅 குறுகிய காலம்Market reaction will align with Q2 operational performance against seasonal industry trends and clarity on the NCLT approval process.
📈 நீண்ட காலம்The segregation into asset-light brand management and capital-heavy asset ownership could unlock value and improve capital efficiency over the medium to long term.
⚠ அபாய எச்சரிக்கைகள்
Regulatory and legal risk regarding timely approval and sanction of the Scheme of Arrangement from NCLT and shareholders
👀 கவனிக்க வேண்டியவை
Track the upcoming NCLT hearings, shareholder meeting notices, and final sanction timelines for the demerger into separate ownership and management platforms.
LXCHEM Q2 Standalone Revenue up 49% YoY to ₹1,055 Cr; PAT Jumps to ₹49.8 Cr
Laxmi Organic Industries reported its Q2 FY27 (quarter ended September 30, 2026) standalone financial results, posting revenue from operations of ₹1,054.63 Cr, a 49.3% increase from ₹706.42 Cr in Q2 FY26. Standalone Profit After Tax surged to ₹49.86 Cr compared to ₹13.94 Cr in the year-ago quarter, although it moderated sequentially from ₹63.30 Cr in Q1 FY27. Basic EPS stood at ₹1.80 for the quarter compared to ₹0.51 in Q2 FY26. Additionally, the Board approved the appointment of Mr. Rajesh Naik as Whole-time Director (Executive Director - Operations) for a 5-year term.
உச்சம் நம்பிக்கை
என்ன மாறியதுReported Q2 FY27 financial results showing robust YoY revenue and profit expansion, and inducted Rajesh Naik into the Board as Executive Director (Operations).
ஏன் இது முக்கியம்Demonstrates strong top-line scale surpassing ₹1,000 Cr in quarterly standalone revenue, recovering strongly from subdued FY26 profit margins despite a sequential dip from Q1.
Standalone Revenue (Q2 FY27): ₹1,054.63 கோடிStandalone PAT (Q2 FY27): ₹49.86 கோடிStandalone Diluted EPS (Q2 FY27): ₹1.79H1 FY27 Revenue: ₹2,012.36 கோடிTerm of ED Operations Appointment: 5 years
📅 குறுகிய காலம்Strong YoY recovery in revenue and profitability is likely to be received positively by the market, although sequential moderation in PAT from Q1 FY27 may cap exuberance.
📈 நீண்ட காலம்Sustained revenue run-rate above ₹1,000 Cr per quarter positions LXCHEM well toward its growth strategy in diketene derivatives and specialty chemicals, with leadership reinforced by experienced operational additions.
⚠ அபாய எச்சரிக்கைகள்
Sequential contraction in PAT from ₹63.30 Cr in Jun 2026 to ₹49.86 Cr in Sep 2026
Volatility in commodity chemical input costs and raw material consumption (₹697.26 Cr in Q2)
👀 கவனிக்க வேண்டியவை
Track the ramp-up of Dahej and Lote facility expansions slated for H2 FY26/FY27, alongside management commentary on specialty chemical pricing realizations and shareholder voting on key board appointments via postal ballot.
Time Technoplast Q2FY27 Presentation: Net Profit Jumps 27% to ₹146 Cr, Revenue Up 32%
Time Technoplast reported strong operational numbers in its Q2 & H1 FY27 earnings presentation, achieving highest-ever quarterly total income of ₹1,996.1 Cr, up 32% YoY. Q2 EBITDA grew 18% YoY to ₹265.0 Cr, while Net Profit increased 27% YoY to ₹146.1 Cr, supported by 13.8% volume growth. For H1 FY27, operating cash flows stood at ₹343.8 Cr, with net debt reduced by ₹95.9 Cr. The company highlighted ongoing order visibility, including a ₹375 Cr packaging tender, ₹210 Cr in composite cylinders (CNG), and ₹195 Cr in PE pipes.
உச்சம் நம்பிக்கை
என்ன மாறியதுRelease of the comprehensive Q2 & H1 FY27 investor presentation showcasing record quarterly revenue and profit alongside asset monetization updates.
ஏன் இது முக்கியம்Demonstrates sustained pricing power and volume growth across packaging and value-added segments like composite cylinders, directly supporting deleveraging and ROCE expansion.
📅 குறுகிய காலம்Earnings presentation details strong volume growth and margin stability, which could reinforce market sentiment around recent quarterly execution.
📈 நீண்ட காலம்Growth in higher-margin value-added segments like Type-III and Type-IV composite cylinders, along with debt reduction from non-core asset sales, supports ROCE enhancement.
⚠ அபாய எச்சரிக்கைகள்
Dependency on polymer pricing stability linked to crude oil
Geopolitical exposure with 34% revenue generated overseas
👀 கவனிக்க வேண்டியவை
Track margin progression given polymer input price fluctuations and monitor the execution timeline for non-core asset sales of ₹116 Cr over the next 18-24 months.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
